Science surrounding the safe use of bioactive ingredients in infant formula: federal comment
- PMID: 36759748
- PMCID: PMC10382303
- DOI: 10.1038/s41390-023-02512-6
Science surrounding the safe use of bioactive ingredients in infant formula: federal comment
Abstract
Less than a quarter of U.S. infants meet the federal recommendation for exclusively breastfeeding to 6 months of age, necessitating access to safe and effective infant formula. The U.S. National Institutes of Health (NIH) and Food and Drug Administration (FDA) held a public Workshop titled “Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework” on September 23rd and September 24th, 2021. Commentary from the NIH and FDA perspectives on the workshop topics is provided in this publication.
Conflict of interest statement
References
-
- Bode L, Raman AS, Murch SH, Rollins NC, Gordon JI 2020. Understanding the mother-breastmilk-infant "triad". Science 367:1070–1072. - PubMed
-
- Goldman AS 2019. Future Research in the Immune System of Human Milk. J Pediatr 206:274–279. - PubMed
-
- Control CfDPa 2022. Breastfeeding Among U.S. Children Born 2012-2019, CDC National Immunization Survey.
-
- NICHD 2020. NICHD Strategic Plan.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
